All Stories

  1. Focus on the Use of Resveratrol in Bladder Cancer
  2. Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives
  3. Procalcitonin as prognostic factor in patients with Fournier’s gangrene
  4. B-TURP versus HoLEP: Peri-Operative Outcomes and Complications in Frail Elderly (>75 y.o.) Patients: A Prospective Randomized Study
  5. Prospective Cross-Sectional Evaluation of Penile Helicine Circulation by Power Doppler During Dynamic Ultrasound in Veno-Occlusive Erectile Dysfunction
  6. Augmentation of Neovaginal Depth using Robotic Peritoneal Flap in Penile Inversion Vaginoplasty
  7. Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function?
  8. The Role of a Multidisciplinary Approach in Gender Affirmation Surgery: What to Expect and Where Are We Currently?
  9. 16 years follow-up evaluation of immediate vs delayed vs. combined hormonal therapy on fertility of patients with cryptorchidism: results of a longitudinal cohort study
  10. Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study
  11. The Role of NGF and Its Receptor TrKA in Patients With Erectile Dysfunction
  12. Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy
  13. Perineal and robot-assisted vesico-urethral reconstruction for anastomotic strictures after RP
  14. Sexual and functional outcomes after prolapse surgery: a randomized prospective comparison of trocarless transvaginal mesh and pelvic organ prolapse suspension
  15. Evaluation of Functional Outcomes and Quality of Life in Elderly Patients (>75 y.o.) Undergoing Minimally Invasive Radical Cystectomy with Single Stoma Ureterocutaneostomy vs. Bricker Intracorporeal Ileal Conduit Urinary Diversion
  16. EDITORIAL COMMENT
  17. COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males
  18. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review
  19. Evaluation of SARS-CoV-2 and semen quality in COVID-19 patients
  20. Clinical use of hyaluronic acid in andrology: A review
  21. Holmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy
  22. The Impact of Lockdown on Couples’ Sex Lives
  23. Li-Eswt improves hemodynamic parameters thus suggesting neoangiogenesis in patients with vascular erectile dysfunction
  24. Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
  25. Resveratrol-Based Multivitamin Supplement Increases Sperm Concentration and Motility in Idiopathic Male Infertility: A Pilot Clinical Study
  26. Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial
  27. Total versus subtotal hysterectomy associated with laparoscopic colposacropexy: A prospective randomized controlled trial
  28. The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue
  29. A “real life” investigation on the prescriptive habits among Italian andrologists: The “CONSER” survey from Italian Society of Andrology (SIA) on Sildenafil oral film
  30. Diagnostic and Therapeutic Workup of Erectile Dysfunction: Results From a Delphi Consensus of Andrology Experts
  31. Transobturator mid-urethral sling in females with stress urinary incontinence and detrusor underactivity: effect on voiding phase
  32. Uterus Preserving Prolapse Repair: How Long does it Last?
  33. The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient’s satisfaction: results from a randomized, two-administration route, cross-over clinical trial
  34. The role of diallyl thiosulfinate associated with nuciferine and diosgenin in the treatment of premature ejaculation: A pilot study
  35. Pelvic muscle floor rehabilitation as a therapeutic option in lifelong premature ejaculation: long-term outcomes
  36. “Nested Type” Bladder Cancer: Myth or Reality?
  37. Sacrocolpopexy with polyvinylidene fluoride mesh for pelvic organ prolapse: Mid term comparative outcomes with polypropylene mesh
  38. Urological dysfunction in young women: an inheritance of childhood?
  39. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study
  40. PD17-01 A SUBANALYSIS OF A RANDOMIZED CONTROLLED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY
  41. PD17-05 LAPAROSCOPIC VERSUS ROBOTIC ASSISTED SACROCOLPOPEXY: A RANDOMIZED, CONTROLLED TRIAL
  42. PD17-04 POLYVINYLDENFLUORID (PVDF) VERSUS POLYPROPYLENE (PP) MESH FOR SACROCOLPOPEXY
  43. The role of detrusor overactivity in urinary incontinence after radical prostatectomy: a systematic review
  44. A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice
  45. Buccal mucosa is a promising graft in Peyronie’s disease surgery. Our experience and a brief literature review on autologous grafting materials
  46. Peak systolic velocity thresholds of cavernosal penile arteries in patients with and without risk factors for arterial erectile deficiency
  47. Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study
  48. MP10-05 SACROCOLPOPEXY FOR POST-HYSTERECTOMY VAGINAL VAULT PROLAPSE: LONG TERM FOLLOW-UP
  49. Sacrocolpopexy for posthysterectomy vaginal vault prolapse: long-term follow-up
  50. 11 Sacrocolpopexy for post-hysterectomy vaginal vault prolapse: Long term follow-up
  51. Genital Lichen Sclerosus in Male Patients: A New Treatment with Polydeoxyribonucleotide
  52. Androgen deprivation therapy (castration therapy) and pedophilia: What’s new
  53. Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial
  54. MP81-18 ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL
  55. PD45-11 SEVERE OBSTRUCTIVE SLEEP APNOEA SYNDROME AND ERECTILE DYSFUNCTION: A PROSPECTIVE RANDOMISED STUDY TO COMPARE SILDENAFIL VS. NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE
  56. Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection
  57. Corporoplasty Using Buccal Mucosa Graft in Peyronie Disease: Is It a First Choice?
  58. The S.A.C.S. (Satisfaction–Anatomy–Continence–Safety) score for evaluating pelvic organ prolapse surgery: a proposal for an outcome-based scoring system
  59. Reconstructive surgery in Peyronie’s disease: What’s new?
  60. Are Early Continence Recovery and Oncologic Outcomes Influenced by Use of Different Devices in Prostatic Apex Dissection During Laparoscopic Radical Prostatectomy?
  61. Long-term Efficacy of the Transobturator and Retropubic Midurethral Slings for Stress Urinary Incontinence: Single-center Update from a Randomized Controlled Trial
  62. Managing female urinary incontinence: A regional prospective analysis of cost-utility ratios (curs) and effectiveness
  63. Severe obstructive sleep apnoea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil vs. nasal continuous positive airway pressure
  64. Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach
  65. Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial
  66. Impact of Clinical and Histopathological Parameters on Disease Specific Survival in Patients with Collecting Duct Renal Cell Carcinoma: Development of a Disease Specific Risk Model
  67. Evaluation of electrospun bioresorbable scaffolds for tissue-engineered urinary bladder augmentation
  68. Glans reconstruction with the use of an inverted urethral flap after distal penile amputation for carcinoma
  69. 1359 DETERIORATION OF CONTINENCE AFTER TOT WHEN THE FOLLOW-UP IS EXTENDED: RESULTS FROM A RANDOMISED CONTROLLED STUDY
  70. Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy
  71. Corporoplasty with small soft axial prostheses (VIRILIS I®) and bovine pericardial graft (HYDRIX®) in Peyronie's disease
  72. Urgency, Detrusor Overactivity and Posterior Vault Prolapse in Women Who Underwent Pelvic Organ Prolapse Repair
  73. Perugia ileal neobladder: functional results and complications
  74. A review of penile metastasis
  75. Correlation between age and Chromogranin A determination in prostate diseases
  76. Prognostic role of tumour multifocality in renal cell carcinoma
  77. 2142 SEXUAL CHANGES AFTER POP REPAIR. IS HYSTERECTOMY A KEY ELEMENT ?
  78. 1872 PREOPERATIVE URINARY INCONTINENCE IS THE MAIN RISK FACTOR FOR POST-OPERATIVE INCONTINENCE IN WOMEN WHO UNDERWENT PELVIC ORGAN PROLAPSE REPAIR
  79. Low serum testosterone levels are predictive of prostate cancer
  80. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series
  81. Prognostic factors in a large multi‐institutional series of papillary renal cell carcinoma
  82. Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study
  83. Pelvic Organ Prolapse Repair With and Without Prophylactic Concomitant Burch Colposuspension in Continent Women: A Randomized, Controlled Trial With 8-Year Followup
  84. Simple Enucleation is Equivalent to Traditional Partial Nephrectomy for Renal Cell Carcinoma: Results of a Nonrandomized, Retrospective, Comparative Study
  85. Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study
  86. Intermittent Androgen Suppression in Prostate Cancer: Testosterone Levels and Its Implication
  87. 1872 OVERACTIVE BLADDER SYMPTOMS (OAB) AND DETRUSOR OVERACTIVITY (DO) IN PATIENTS WITH POSTERIOR VAULT PROLAPSE: PREVALENCE AND ITS CHANGES AFTER POP REPAIR
  88. Managing Mesh Erosion after Abdominal Pelvic Organ Prolapse Repair: Ten Years’ Experience in a Single Center
  89. Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience
  90. Uterus preservation in pelvic organ prolapse surgery
  91. Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?
  92. 1510 FEMALE SEXUAL FUNCTION EVALUATION IN PATIENTS UNDERWENT TO INTEGRAL PELVIC FLOOR RECONSTRUCTIVE SURGERY
  93. 1503 LONG-TERM OUTCOME OF ANTI-INCONTINENCE PROCEDURE DURING PELVIC ORGAN PROLAPSE REPAIR IN PATIENTS WITH OR WITHOUT URINARY INCONTINENCE. RESULTS FROM TWO RANDOMISED SURGICAL TRIALS
  94. 1101 PENILE RESCULPTURING IN SURGERY OF M. PEYRONIE: RESTORATION OF PENILE LENGTH, GIRTH AND SHAPE WITH OR WITHOUT PENILE PROSTHESIS IMPLANTATION
  95. 1075 REAL PENILE LENGTHENING AND WIDENING IN PROSTHETIC SURGERY FOR ED
  96. Iatrogenic Trapped Penis in Adults: New, Simple 2-Stage Repair
  97. Patients of surgical educational course may have a poorer outcome for pelvic organ prolapse repair and higher complication rate: a case-control study in urogynecology
  98. Outcomes of Radical Prostatectomy in Clinically Locally Advanced N0M0 Prostate Cancer
  99. Erectile dysfunction and NO: variations of NO penile blood levels before and after sildenafil treatment
  100. Surgical Treatment of Peyronie's Disease by Plaque Incision and Grafting with Buccal Mucosa
  101. Editorial Comment on: Surgical Treatment of Peyronie's Disease by Plaque Incision and Grafting with Buccal Mucosa
  102. LONG-TERM FOLLOW-UP OF UTERUS SPARING SURGERY FOR PELVIC ORGAN PROLAPSE (POP)
  103. IS SURGICAL OUTCOME AT RISK DURING POST-GRADUATED EDUCATIONAL COURSES FOR STRESS URINARY INCONTINENCE (SUI) AND PELVIC ORGAN PROLAPSE (POP) REPAIR? A CASE CONTROL STUDY
  104. Hydronephrosis and Pelvic Organ Prolapse
  105. Visually Directed Transrectal High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Preliminary Report on the Italian Experience
  106. Open-Label, Longitudinal Study of Tamsulosin for Functional Bladder Outlet Obstruction in Women
  107. Bladder and Urethral Sphincter Function after Radical Retropubic Prostatectomy: A Prospective Long-Term Study
  108. Burch Colposuspension Does Not Provide Any Additional Benefit to Pelvic Organ Prolapse Repair in Patients With Urinary Incontinence: A Randomized Surgical Trial
  109. PREOPERATIVE MUCP AND VLPP FAILED TO PREDICT OUTCOME IN PATIENTS WHO UNDERWENT TRANSOBTURATOR MID-URETHRAL SLINGS
  110. SIX YEARS FOLLOW UP OF BOTULINUM A TOXIN INTRADETRUSORIAL INJECTIONS IN PATIENTS WITH REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY: CLINICAL AND URODYNAMIC RESULTS
  111. Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup
  112. Testosterone Levels in Benign Prostatic Hypertrophy and Prostate Cancer
  113. Female Sexual Dysfunction in Urogenital Prolapse Surgery: Colposacropexy vs. Hysterocolposacropexy
  114. Is There Any Clinical Parameter Able to Predict Prostate Cancer after Initial Diagnosis of Atypical Small Acinar Proliferation?
  115. Alteration of glyoxalases gene expression in response to testosterone in LNCaP and PC3 human prostate cancer cells
  116. Must Colposuspension be Associated with Sacropexy to Prevent Postoperative Urinary Incontinence?
  117. Botulinum-A Toxin Injections Into the Detrusor Muscle Decrease Nerve Growth Factor Bladder Tissue Levels in Patients With Neurogenic Detrusor Overactivity
  118. Sleep Hygiene and Melatonin Treatment for Children and Adolescents With ADHD and Initial Insomnia
  119. Overexpression of Glyoxalase System Enzymes in Human Kidney Tumor
  120. Varicocele and Fertility: Relationship Between Testicular Volume and Seminal Parameters Before and After Treatment
  121. Cytosolic calcium levels in spermatozoa are modulated differently in healthy subjects and patients with varicocele
  122. Treatment of Urethral Syndrome: A Prospective Randomized Study with Nd:YAG Laser
  123. Uterus Preservation in Surgical Correction of Urogenital Prolapse
  124. Recovery of sexual function after nerve-sparing radical retropubic prostatectomy: is cavernous nitric oxide level a prognostic index?
  125. Treatment of Varicocele: Randomized Prospective Study on Open Surgery Versus Tauber Antegrade Sclerotherapy
  126. Lichen Sclerosus of the Male Genitalia and Urethral Stricture Diseases
  127. Color Doppler Ultrasonography in the Diagnosis of Vascular Abnormalities Associated with Ureteropelvic Junction Obstruction
  128. Four-corner colposuspension: clinical and functional results
  129. Renal Cell Carcinoma: Histological Findings on Surgical Margins After Nephron Sparing Surgery
  130. Stage pT1 Renal Cell Carcinoma: Review of the Prognostic Significance of Size
  131. Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas
  132. PRIMARY BURKITT???S LYMPHOMA OF BLADDER IN PATIENT WITH AIDS
  133. Peyronie’s Disease: Corporoplasty Using Saphenous Vein Patch Graft
  134. Quand et pourquoi la prothèse pénienne : sept ans d'expérience
  135. Ureterointestinal Anastomosis in Orthotopic Neobladders
  136. Detubularized rectosigmoid neobladder in women after cystectomy for bladder cancer
  137. Penile Prosthesis Implantation and Couple’s Satisfaction
  138. Open Prostatectomy in Benign Prostatic Hyperplasia: 10-Year Experience in Italy
  139. Implant Surgery in Peyronie’s Disease